NVO Novo Nordisk LLY Eli Lilly: CagriSema Delivers Superior Weight Loss vs. Tirzepatide in REIMAGINE 5 ⠀ · CagriSema patients lost 12.4% of body weight at Week 60 vs. 9.1% with tirzepatide. · Trial used a 1.0 mg dose of each CagriSema component.